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SUMMARY
A scoping review was conducted to identify modifiable non-antimicrobial factors to reduce the
occurrence of antimicrobial resistance in cattle populations. Searches were developed to retrieve
peer-reviewed published studies in animal, human and in vitro microbial populations. Citations
were retained when modifiable non-antimicrobial factors or interventions potentially associated
with antimicrobial resistance were described. Studies described resistance in five bacterial genera,
species or types, and 40 antimicrobials. Modifiable non-antimicrobial factors or interventions
ranged widely in type, and the depth of evidence in animal populations was shallow. Specific
associations between a factor or intervention with antimicrobial resistance in a population
(e.g. associations between organic systems and tetracycline susceptibility in E. coli from cattle)
were reported in a maximum of three studies. The identified non-antimicrobial factors or
interventions were classified into 16 themes. Most reported associations between the non-
antimicrobial modifiable factors or interventions and antimicrobial resistance were not
statistically significant (P > 0·05 and a confidence interval including 1), but when significant, the
results were not consistent in direction (increase or decrease in antimicrobial resistance) or
magnitude. Research is needed to better understand the impacts of promising modifiable factors
or interventions on the occurrence of antimicrobial resistance before any recommendations can
be offered or adopted.
Key words: Antibiotic resistance, antimicrobial resistance in agricultural settings, epidemiology,
veterinary epidemiology.
INTRODUCTION
Shortly after the discovery of antimicrobials and their
introduction into clinical practice, acquired antimicro-
bial resistance was observed to adversely impact
clinical outcomes [1]. As antimicrobial resistance
threatens the efficacy of antimicrobial treatment for
bacterial infections in any animal species, it is a
topic of much research in the human, veterinary, agri-
food and environmental sectors. The epidemiology of
antimicrobial resistance is complex and involves links
between humans, animals and the environment, in-
cluding the transmission of antimicrobial-resistant
bacteria within and between these niches. Public
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health concerns about the transmission of antimicro-
bial resistant foodborne pathogens or genes through
the food chain have existed for decades. These con-
cerns continue with the isolation of extended-spectrum
cephalosporin- [2] and carbapenem-resistant [2–4] E.
coli and Salmonella enterica in livestock.
Human acquisition of bacteria carrying antimicro-
bial resistance genes from cattle and other farmed ani-
mals may occur by direct animal contact, via the food
chain, or through contamination of the environment.
Consumption of beef products has been linked to
foodborne outbreaks of infection including those
caused by antimicrobial-resistant bacteria [5].
Infection with antimicrobial-resistant organisms has
been associated with more adverse health outcomes
compared to infection with pan-susceptible strains.
For example, patients with antimicrobial resistant
Salmonella were at greater risk of hospitalization,
increased duration of hospitalization and bloodstream
infections [5]. Because of the adverse human health
outcomes and the emergence of resistance in animals
and food to antimicrobials of notable public health
importance [2, 4], determining modifiable factors or
interventions to reduce the occurrence of antimicro-
bial resistance in cattle populations is desirable.
Antimicrobial resistance is a broad, widely re-
searched topic with a large volume of peer-review
published research. Links between antimicrobial uses
in agriculture with antimicrobial resistance in human
health have been documented [6–14]. Consequently,
some interventions that focus on reduction of antimi-
crobial use have been applied in certain agricultural
settings to mitigate the transfer of antimicrobial resistant
bacteria or determinants along the food chain [11, 15].
However, modifiable non-antimicrobial factors or
interventions may also contribute to a reduction in
the transfer of resistant bacteria or determinants and
a reduction in the occurrence of antimicrobial resist-
ance. Modifiable non-antimicrobial factors are factors
other than antimicrobial use or exposure that may be
changed to alter the occurrence of antimicrobial resist-
ance such as type of production system (conventional
or non-conventional), stocking density and hygiene.
The relationships of non-antimicrobial factors to anti-
microbial resistance may be direct, but likely also have
relationships with illness, antimicrobial treatment and
use, other routes of antimicrobial exposure and each
other. Modifying non-antimicrobial factors may
impact the occurrence of antimicrobial resistance
through more than one causal pathway. A structured
synthesis of published research is required to more
fully understand the current state of knowledge, to
identify plausible and practical non-antimicrobial
interventions, and to identify and prioritize research
needs and knowledge gaps.
The scoping review is a newer method of review
with over 70% of scoping reviews in the health sector
published since 2010 [16]; notably, they have also been
employed in the agri-food research arena [17–19].
Scoping review methodologies are appropriate for
the review of broad topics [20] and they can be used
to map the distribution and characteristics of a par-
ticular topic or issue, summarize the state of knowl-
edge, identify research gaps and inform future
research, provide data to stakeholders, and help
prioritize questions for more focused systematic re-
view [20]. Our research question was: What modifiable
non-antimicrobial factors or interventions have the
potential to decrease the prevalence of organisms
with phenotypic or genotypic expression of resistance,
to decrease the populations of organisms carrying
resistance genes, or to prevent the accumulation of re-
sistance (i.e. reduce selection pressure for resistance) in
North American cattle production systems? The scop-
ing review approach was a better fit to our broad re-
search question than the more focused systematic
review method. We searched for, and reviewed,
published peer-reviewed English-language literature
(without geographical limitations) covering animal
populations with additional data arising from
human populations and in vitro studies to identify,
characterize, and summarize potential modifiable
non-antimicrobial interventions in order to reduce
the occurrence of antimicrobial resistance among en-
teric bacteria in North American cattle populations.
MATERIALS AND METHODS
Search terms and strategy
Using the research question stated above, searches
were developed to return citations of investigations
into non-antimicrobial factors associated with anti-
microbial resistance in animal populations, human
populations and in vitro (Fig. 1). For animal popu-
lation citations, the search focused on antimicrobial
resistance in enteric or faecal bacteria and used mul-
tiple broad and specific search terms for antimicrobial
susceptibility and animal population (Supplementary
Appendix 1, available online). This search used eight
databases in the OVID platform (Medline, EMBASE,
CAB abstracts, Biosis, Zoological Records, Agris,
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Global Health, Food Science) as well as three databases
through the Proquest, formerly Cambridge Scientific
Abstracts (CSA), interface (Agricola, Biological
Sciences, Toxline) and was performed from 12 June to
13 July 2011. The search for citations of studies conduc-
ted in human populations or in vitro included general
and specific terms for bacteria (e.g. Enterobacteriaceae
or Enterococcus or Escherichia coli), general antimicro-
bial susceptibility terms, terms related to changing anti-
microbial susceptibilities (e.g. affect or effect or reduce
or decrease), and factors or interventions related to par-
ticular actions (e.g. infection control) or pharmacology
(e.g. dose-response relationship, pharmacodynamics)
(Supplementary Appendix 2). Medline and CAB
Abstracts were searched from 13 October to 31
December 2011. All searches included all available
years of the databases, all geographical locations
and were limited to those published in English. All
citations were exported and de-duplicated (electroni-
cally and manually) in a web-based bibliographical
database manager (RefWorks 2.0; http://www.ref-
works.com/).
Relevance screening of abstracts and full-text citation
Each abstract (or title only, where no abstract was
available) was screened using the question: ‘Does
this citation describe modifiable non-antimicrobial
Citations retrieved from database searching and screened
by abstract or title
NSA=2246       NSH=24814
Citations excluded=24313
Reason: No modifiable factors or interventions were
reported
Citations reviewed by full text
N=2747
Citations excluded=2241
Reasons:
1) No modifiable factors or interventions were
reported
2) No non-antimicrobial-related factor or
intervention reported
3) Only non-satistically significant assocations
reported in human-population only or entirely
in vitro references
Studies with modifiable non-
antimicrobial factors or
interventions
NA=82
Studies with tested associations between modifiable
factors and antimicrobial resistance and included in
qualitative assessment
NA=61
Studies retained following qualitative assessment
NA=39
Studies with significant
associations between
modificable factors and
antimicrobial resistance
NH=356     NIV=68
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Fig. 1. PRISMA flow chart documenting the literature retrieval* and inclusion/exclusion criteria for citations to identify
modifiable non-antimicrobial factors or interventions to reduce the occurrence of antimicrobial resistance in cattle
production systems. (* NSA, Search designed to return citations studying animal populations. NSH, Search designed to
return citations studying human or in vitro populations. NH, Citations studying human-only populations. NIV, Citations
studying entirely in vitro populations. NA, Citations studying animal populations.)
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interventions that may change antimicrobial resist-
ance, or else modifiable factors that may be associated
with antimicrobial resistance’? Citations reporting
modifiable factors or interventions were retained,
and citations reporting only non-modifiable factors
such as breed, sex, or geographical location were
excluded. Full text citations were screened with the
same question as the abstracts. All screening of
abstracts and review of full text citation was per-
formed independently by two reviewers. The review
team included three veterinary epidemiologists with
expertise in the subject matter, a veterinary pharma-
cologist and a research assistant. Citations were in-
cluded in the review or excluded with complete
agreement by the two reviewers. In the case of dis-
agreement, the citation was included or excluded on
the basis of a review by a third member of the team.
Data extraction from citations of studies investigating
non-antimicrobial use interventions or factors
Data on the following were extracted from full-text
citations of studies conducted in animal populations
(including studies also involving a human population):
animal species, study design, reported modifiable non-
antimicrobial risk factors and interventions, referent
or control group, bacteria or bacterial genes isolated,
antimicrobial susceptibility or antimicrobial resistance
genes, the association(s) between antimicrobial sus-
ceptibility and non-modifiable risk factors (i.e. signifi-
cant, non-significant), and the direction of the
associations. Multiple drug resistance was extracted
from those studies where multiple drug resistance
was defined and investigated, and from studies
where susceptibility to two or more antimicrobials in
combination was reported (excluding the combina-
tions of trimethoprim-sulfamethoxazole and quinpris-
tin-dalfopristin).
For exclusively human or in vitro studies, extracted
data were limited to study population, study design,
modifiable factor or intervention, and the direction
of the associations. We placed this limitation because
data from studies conducted in animal populations
were assumed to be of greater relevance to our objec-
tive, and the much larger volume of citations in
human populations exceeded our capacity for full
data extraction. Thus, resources were mainly allocated
to detailed data extraction from animal population
studies and their qualitative review (see below).
For all studies, specific modifiable non-antimicro-
bial factors and interventions were aggregated into
categories. The categories were not established a priori,
but were developed iteratively by two independent
reviewers. Separate categories were developed for stu-
dies in animal, human and in vitro populations, and
the categories were then reviewed and evaluated quali-
tatively for common themes.
Quality assessment of animal-population studies
An assessment was made of the quality of studies in
animal populations only. Any studies reporting only
descriptive or raw data were excluded from the
assessment. The purpose of the assessment was to
identify and remove from the review any studies
with methodological flaws or biases that would ad-
versely affect the validity of the scoping review. This
quality assessment instrument was a pretested ques-
tionnaire that was adapted from the GRADE assess-
ment and risk-of-bias approach [21] (Supplementary
Appendix 3). Two reviewers independently evaluated
the stated inclusion/exclusion criteria for observa-
tional studies, or group allocation for randomized or
experimental studies, assessed the impact of randomi-
zation (or lack of randomization) where appropriate,
evaluated appropriateness of the statistical analysis,
reviewed whether other procedures were defined, ap-
propriate and used correctly, and determined if biases
or uncontrolled confounders may have influenced the
validity of the results. Studies were ranked either as
high, moderate, or low quality, or else unreliable. In
cases of disagreement, a third person reviewed the
study, which was then classified on the basis of the
third review. Only those studies ranked as being of
high or moderate quality were retained.
RESULTS
Of the 27 060 de-duplicated citations, 506 reported on
modifiable non-antimicrobial factors or interventions.
Most of these described studies in human populations
exclusively (n = 356, 70%), 16% (n= 82) involved an-
imal populations, and 13% (n = 68) were conducted
entirely in vitro (Fig. 1). Of the retained citations in-
volving human and animal populations, the most
common study type was observational (n = 366,
93%) (Figs 2 and 3).
The animal populations studied in the retained stu-
dies after the qualitative assessment (n = 39) were cat-
tle (n= 18), pigs (n= 17), chickens (n= 2) and dogs
(n = 2). There were five bacterial genera, species or
types investigated individually or in combination:
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E. coli (n= 21, 54%), Salmonella enterica (n= 8, 20%),
Campylobacter species (n= 7, 18%), coliforms (n= 5,
13%), and Enterococcus species (n= 3, 8%). Two stu-
dies investigated antimicrobial resistance genes. Most
studies examined only one bacterial genus or species
(n= 31, 79%), 15% (n= 6) studied two and 5% (n= 2)
studied three. Overall, antimicrobial susceptibility to
40 different antimicrobials from 14 antimicrobial
classes was reported (Table 1), and the median num-
ber of antimicrobials included in a study was three
Fig. 2. Numbers of citations by study type reporting statistically significant results between non-antimicrobial factors and
antimicrobial resistance in human populations.
Fig. 3. Distribution of study design from retained citations studying non-antimicrobial factors associated with antimicrobial
resistance in animal populations.
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Table 1. Descriptions of non-antimicrobial factors, tested antimicrobials, bacteria and, animal species in animal population citations (n = 39) that investigated
associations between antimicrobial resistance and non-antimicrobial factors
Antimicrobial class Antimicrobial (n*) Bacteria (n*) Animal species (n*) Description of factor(s) Reference
Aminoglycosides Apramycin (n= 5) E. coli (n= 5),
Salmonella enterica
(n= 1)
Pig (n= 4), cow
(n= 1)
Non-conventional management†;
Contact with other animals treated
with antimicrobials; Treatment
with oral competitive exclusion
culture made from piglets
[28–32]
Gentamicin (n= 12) E. coli (n= 6),
Enterococcus species
(n= 1),
Campylobacter
species (n= 3)
Cow (n= 5), pig
(n= 5), chicken
(n= 2)
Non-conventional management;
Feeding silage or grain; Dietary
zinc or copper
[32–43]
Kanamycin (n= 9) E. coli (n= 4),
Campylobacter
species (n= 1),
Salmonella enteria
(n= 3), coliforms
(n= 2)
Pig (n= 4), cow
(n= 3), chicken
(n= 2)
Non-conventional management [32, 33, 35, 37, 39, 40, 43–45]
Neomycin (n= 4) E. coli (n= 2),
coliforms (n= 2)
Cow (n= 1), pig
(n= 3)
Non-conventional management [44–47]
Spectinomycin (n= 1) Enterococcus species
(n= 1)
Pig (n= 1) Herd size; Bringing new animals
onto the farm
[36]
Streptomycin (n= 14) E. coli (n= 7),
Campylobacter
species (n= 2),
Salmonella enterica
(n= 2)
Cow (n= 5), pig
(n= 7), chicken
(n= 2)
Non-conventional management;
Health status; Treatment with oral
competitive exclusion culture made
from piglets; Dietary zinc or
copper; Pen/group/herd size;
Number of suppliers; Education;
Bringing new animals onto the farm
[32, 33, 35, 37–39, 44–49]
Vancomycin (n= 2) Enterococcus species
(n= 2)
Cow (n= 2) Non-conventional management;
Dietary zinc and copper
[38, 50]
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Table 1 (cont.)
Antimicrobial class Antimicrobial (n*) Bacteria (n*) Animal species (n*) Description of factor(s) Reference
β-lactams Ampicillin (n= 18) E. coli (n= 9),
Salmonella enterica
(n= 3),
Campylobacter
species (n= 1),
coliforms (n= 4)
Pig (n= 6), cow
(n= 8); chicken
(n= 2), dog
(n= 2)
Non-conventional management;
Diet associated with a risk of
ruminal acidosis; Bringing new
animals onto the farm; Pen/group/
herd size; Treatment with oral
competitive exclusion culture made
from piglets; Education; Oral
recombinant β-lactamase
administration in dogs treated with
parenteral ampicillin.
[28, 32–37, 39, 40, 43–45, 47, 50–54]
Amoxicillin-clavulanic
acid (n= 7)
E. coli (n= 4),
Salmonella enterica
(n= 3),
Campylobacter
species (n= 1)
Pig (n= 2), cow
(n= 3); chicken
(n= 2)
Non-conventional management;
Bringing new animals onto the
farm; Pen/group/herd size
[32, 33, 35, 37, 39, 40, 43]
Carbenicillin (n= 1) Coliforms (n= 1) Pig (n= 1) Non-conventional management [45]
Cefoxitin (n= 5) E. coli (n= 3),
Salmonella enterica
(n= 2)
Pig (n= 2), cow
(n= 3), chicken
(n= 1)
Non-conventional management;
Bringing new animals onto the
farm; Pen/group/herd size
[32, 33, 39, 43, 50]
Ceftiofur (n= 5) E. coli (n= 3),
Salmonella enterica
(n= 2)
Pig (n= 2), cow
(n= 2), chicken
(n= 1)
Non-conventional management;
Pen/group/herd size
[33, 35, 39, 43, 54]
Ceftriaxone (n= 7) E. coli (n= 3),
Salmonella enterica
(n= 3),
Campylobacter
species (n= 1),
Enterococcus species
(n= 1)
Pig (n= 2), cow
(n= 3), chicken
(n= 2)
Non-conventional management;
Pen/group/herd size
[33, 35, 37, 39, 40, 43, 50]
Cephalothin (n= 8) E. coli (n= 4),
Salmonella enterica
(n= 3), coliforms
(n= 1)
Pig (n= 2), cow
(n= 3), chicken
(n= 2), dog
(n= 1)
Non-conventional management;
Bringing new animals onto the
farm; Pen/group/herd size; Oral
recombinant β-lactamase
administration in dogs treated with
parenteral ampicillin
[32, 33, 35, 39, 40, 43, 52, 54]
Penicillin (n= 4) E. coli (n= 1),
Enterococcus species
(n= 2), coliforms
(n= 1)
Pig (n= 1), cow
(n= 3)
Non-conventional management;
Dietary copper and zinc
[38, 44, 50, 54]
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Table 1 (cont.)
Antimicrobial class Antimicrobial (n*) Bacteria (n*) Animal species (n*) Description of factor(s) Reference
TEM genes (n= 1) Dog (n= 1) Oral recombinant β-lactamase
administration in dogs treated with
parenteral ampicillin
[51]
Carbadox Carbadox (n= 2) E. coli (n= 2) Pig (n= 2) Ration supplemented with egg yolk
with anti-Salmonella antibody;
Bringing new animals onto the farm
[31, 36]
Lipopeptide Daptomycin (n= 1) Enterococcus species
(n= 1)
Cow (n= 1) Non-conventional management [50]
Macrolides Azithromycin (n= 2) Campylobacter
species (n= 2)
Pig (n= 1), cow
(n= 1)
Non-conventional management [37, 42]
Erythromycin (n= 6) E. coli (n= 1),
Campylobacter
species (n= 5),
Enterococcus species
(n= 1)
Pig (n= 3), cow
(n= 3)
Non-conventional management;
Ad libitum or restricted feeding;
Dietary copper and zinc; Health
status
[37, 38, 41, 42, 44, 49, 50]
Macrolides (n= 2) E. coli (n= 1),
Campylobacter
species (n= 1)
Pig (n= 1), cow
(n= 1)
Steamed flaked corn with or without
wet distillers; Dietary copper
[55, 56]
Tilmicosin (n= 1) E. coli (n= 1) Cow (n= 1) Dietary copper and zinc [38]
Tylosin (n= 2) E. coli (n= 1),
Enterococcus species
(n= 1)
Cow (n= 2) Non-conventional management;
Dietary copper and zinc
[38, 50]
ermB gene (n= 1) Coliforms (n= 1) Cow (n= 1) Steamed flaked corn with or without
wet distillers
[55]
Nitrofurans Nitrofurantoin (n= 1) Enterococcus species
(n= 1)
Pig (n= 1) Pen/group/herd size; Bringing new
animals onto a farm
[36]
Oxazolidinones Linezolid (n= 2) Enterococcus species
(n= 2)
Cow (n= 2) Non-conventional management;
Dietary copper and zinc
[38, 50]
Phenicols Chloramphenicol
(n= 10)
E. coli (n= 5),
Enterococcus species
(n= 2), Salmonella
enteria (n= 2),
Campylobacter
species (n= 2)
Cow (n= 6), pig
(n= 3), chicken
(n= 1)
Non-conventional management;
Dietary copper and zinc; Pen/
group/herd size; Number of
suppliers; Bringing new animals
onto the farm
[32, 35, 37–41, 43, 47, 50]
Florfenicol (n= 1) Campylobacter
species (n= 1)
Cow (n= 1) Non-conventional management [37]
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Table 1 (cont.)
Antimicrobial class Antimicrobial (n*) Bacteria (n*) Animal species (n*) Description of factor(s) Reference
Phosphoglycolipid Flavomycin (n= 2) Campylobacter
species (n= 1),
Enterococcus species
(n= 1)
Cow (n= 2) Non-conventional management;
Steamed corn with or without wet
distillers
[50, 55]
Pleuromutilin Tiamulin (n= 1) E. coli (n= 2) Cow (n= 2) Dietary copper and zinc [38]
Quinlones/
Fluoroquinolones
Ciprofloxacin (n= 8) E. coli (n= 3),
Campylobacter
species (n= 4),
Enterococcus species
(n= 1)
Pig (n= 5), cow
(n= 3)
Non-conventional management;
All-in/all-out system; Dietary
copper and zinc; Ration with or
without whey; Ad libitum or
restricted feeding Health status;
Disinfection; Rodent control
[35, 37–39, 41–43, 49]
Nalidixic acid (n= 7) E. coli (n= 3),
Campylobacter
species (n= 4)
Pig (n= 4), cow
(n= 3)
Non-conventional management;
Pen/group/herd size
[35, 37, 39, 41–43, 47]
Streptogamins Quinpristin/dalfopristin
(n= 1)
Campylobacter
species (n= 1)
Cow (n= 1) Steamed flaked corn with or without
wet distillers
[55]
Sulphonamides/
Pyrimidines
Sulfadimethoxine
(n= 2)
E. coli (n= 2) Cow (n= 2) Non-conventional management;
Steamed flaked corn with or
without wet distillers
[54, 55]
Sulfamethizole (n= 1) Coliforms (n= 1) Pig (n= 1) Non-conventional management [44]
Sulfamethoxazole
(n= 6)
E. coli (n= 5),
Campylobacter
species (n= 1)
Pig (n= 2), cow
(n= 4)
Non-conventional management;
Pen/group/herd size; Number of
supplies; Bringing new animals
onto the farm; Education
[32, 35, 37, 39, 43, 47]
Sulfasoxazole (n= 3) E. coli (n= 2),
Salmonella enterica
(n= 1), coliforms
(n= 1)
Pig (n= 2), chicken
(n= 1)
Non-conventional management;
Pen/group/herd size; Bringing new
animals onto the farm
[40]
Sulfathiazole (n= 1) E. coli (n= 1) Cow (n= 1) Steamed flaked corn with or without
wet distillers
[55]
Sulfachloropyridazine
(n= 1)
E. coli (n= 1) Cow (n= 1) Steamed flaked corn with or without
wet distillers
[55]
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Table 1 (cont.)
Antimicrobial class Antimicrobial (n*) Bacteria (n*) Animal species (n*) Description of factor(s) Reference
Trimethoprim-
sulfamethoxazole
(n= 6)
E. coli (n= 5),
Salmonella enterica
(n= 1), coliforms
(n= 1)
Pig (n= 2), cow
(n= 2), dog
(n= 1)
Non-conventional management;
Pen/group/herd size; Number of
suppliers; Education; Bringing new
animals onto the farm; Oral
recombinant β-lactamase
administration in dogs treated with
parenteral ampicillin
[32, 35, 39, 43, 47, 52]
Tetracyclines Tetracycline (n= 21) E. coli (n= 11),
Salmonella enterica
(n= 3),
Campylobacter
species (n= 6),
Enterococcus species
(n= 1), coliforms
(n= 1)
Pig (n= 12), cow
(n= 6), chicken
(n= 2), dog
(n= 1)
Non-conventional management;
All-in/all-out; Ventilation system;
Contact with animals treated with
antimicrobials; Disinfection and
sanitation; Ration supplemented
with egg yolk with anti-Salmonella
antibody; Flooring; Pen/group/herd
size; Diet associated with a risk of
ruminal acidosis; Education;
Bringing new animals onto the
farm; Number of suppliers;
Treatment with oral competitive
exclusion culture made from
piglets; Oral recombinant
β-lactamase administration in dogs
treated with parenteral ampicillin;
Health status; Silage vs. a grain
based ration.
[28, 30–37, 39–45, 47, 49, 50, 52–54, 57, 58]
tetM gene (n= 1) Cow (n= 1) Steamed flaked corn with or without
wet distillers
[55]
Other Any resistance (n= 5) E. coli (n= 3),
Salmonella enterica
(n= 1), coliforms
(n= 1)
Cow (n= 3), pig
(n= 2)
Non-conventional management;
All-in/all-out; Pen/group/herd size;
Health status
[45, 59–62]
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(range 1–16) (Fig. 4). There were 485 associations be-
tween specific modifiable factors or interventions and
antimicrobial susceptibility (or genes in a specific bac-
terial species) reported, and specific bacteria/antimi-
crobial susceptibility combinations (e.g. E. coli and
tetracycline) occurred at a frequency of 45%. The
most frequent combinations were E. coli and tetracy-
cline, ampicillin, apramycin, gentamicin, or strepto-
mycin, and Campylobacter species and ciprofloxacin
(Table 2).
Specific associations between a given factor or inter-
vention with antimicrobial resistance in a given
animal population (e.g. the association between non-
conventional management and tetracycline suscepti-
bility in E. coli from cattle) were reported in only a
small number (range 1–3) of studies. The majority
(n= 303, 62%) of specific associations were reported
in only one study, 24% (n= 115) were reported in
two studies, and 14% (n= 67) were reported in three
studies.
Most reported associations between antimicrobial
susceptibility and a modifiable non-antimicrobial fac-
tor or intervention were not statistically significant
(60%, n= 290), 27% (n= 132) (27%) of the associa-
tions were interpreted as significant [P40·05 and
confidence interval (where reported) that excluded 1]
and the remainder of the associations that were
reported (n= 63, 13%) were descriptive in nature or
else raw data (Table 3). Use of a non-conventional
management systems (e.g. organic, antimicrobial-free,
extensive systems), increasing herd, group or pen size
and all-in/all-out systems were the factors with the
greatest number of reported associations (n= 183, 68
and 52, respectively). For the factors of non-
conventional management systems and increasing
herd, group or pen, most associations were non-
significant (64% and 90%, respectively); however, the
majority (83%) of the associations for all-in/all-out
systems were significantly associated with a decrease
in antimicrobial resistance.
In the retained studies from human and in vitro
populations (n = 424) (Table 4), most factors were
associated with an increase, rather than decrease in
antimicrobial resistance. The most frequently reported
factor (n= 289, 68%) was the duration of hospitaliza-
tion (or time spent in the intensive care unit or in
another ward).
Considering combined data from human, animal
and in vitro populations, 16 common themes were
observed (Table 5). These themes reflected aspects
on the use of compounds (e.g. vaccinations,T
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probiotics, and recombinant b-lactamases), infection
control (e.g. cleaning and disinfection, hospital vs.
home pens), health (comorbidity, stressors, immuno-
suppression), education and relationships with
professionals (infection disease consultations, partici-
pation in quality assurance programmes) and others.
Studies in animal populations were represented in
all themes despite fewer studies retained (n = 39)
compared to retained studies in human populations
(n = 356) or entirely in vitro studies (n= 68). Studies
performed in human populations or entirely in vitro
belonged to only 50% (n= 8) of the themes and be-
longed to themes identified in animal populations.
DISCUSSION
Using scoping review methodology, we identified the
evidence supporting use of non-antimicrobial factors
or interventions for reduction of antimicrobial resist-
ance with particular emphasis on animal populations.
We also assessed the quantity and quality of this evi-
dence, as well as the distribution of antimicrobials
selected for susceptibility testing in enteric bacteria,
the distribution of enteric bacteria investigated and
the populations studied (animal, human, in vitro) in
a transparent, reproducible manner.
An important finding of this review was the wide
breadth of data on non-antimicrobial factors asso-
ciated with antimicrobial resistance; however, the
depth of research supporting effect measures for
these factors was limited, particularly concerning
any specific factor for any particular antimicrobial/
bacterial combination in any particular animal popu-
lation. The limited depth of applicable research in an-
imal populations is perhaps somewhat offset by
0
2
4
6
8
10
12
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Number of antimicrobials tested for susceptibility
N
um
be
r o
f c
ita
tio
ns
Median
Fig. 4. Number of antimicrobials* tested for susceptibility in in animal population citations reporting associations
between non-antimicrobial factors or interventions and antimicrobial resistance. [* Including ‘any resistance’ (as defined
by the authors) or multiple drug resistance (as defined by the authors) or any two or more antimicrobial combinations
reported (excluding trimethoprim-sulfamethoxazole and quinpristin-dalfopristin).]
Table 2. The most frequently* identified bacteria/
antimicrobial/species combinations reported from
retained citations (n = 39) in animal populations that
investigated the associations between modifiable
non-antimicrobial factors or interventions and
antimicrobial resistance.
Combination Animal No. Frequency*
E. coli/tetracycline 26 5%
Pig 17
Cow 9
E. coli/ampicillin 17 4%
Pig 10
Cow 7
E. coli/apramycin 15 3%
Pig 12
Cow 3
Campylobacter/ciprofloxacin 15 3%
Pig 14
Cow 1
E. coli/gentamicin 13 3%
Pig 8
Cow 5
E. coli/streptomycin 13 3%
Pig 6
Cow 7
*Denominator was total number of associations reported in
‘reliable’ studies (n= 485). All other bacteria/antimicrobial
combinations were identified at a frequency of < 2%.
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similar research in human populations, from which
some analogies may be drawn.
Another key finding of this review was that most of
the non-antimicrobial factors or interventions tested
in animal populations were not significantly asso-
ciated with antimicrobial resistance. Additionally,
where significant associations were reported, they
were not generally in a single direction (either
Table 3. Direction of effect of associations between modifiable non-antimicrobial factors or interventions and
antimicrobial resistance in retained citations (n = 39) in animal populations
Factor or intervention Species
Increase
antimicrobial
resistance (no. of
associations)
Decrease
antimicrobial
resistance (no. of
associations)
Not statistically
associated with
antimicrobial resistance
(no. of associations)
Contact with animals
Contact with animals treated
with antimicrobials
Pig 1 3
Diet
Addition of egg yolk anti-
Salmonella antibody to
a ration
Pig 8 7
Addition of whey to a ration Pig 1
Ad libitum feeding when
compared to restricted feeding
Pig 1
Addition of wet distillers to a
ration of steamed flaked corn
Cow 3 1 4
A diet associated with a low
risk of ruminal acidosis
Cow 1 1
Addition of S. cerevisisae
boulardii to milk replacer
Cow 1 1
Dietary zinc or copper above
NRC recommendation
Cow 1 26
Health status
Unhealthy animals Cow, pig 5 1
Routine deworming Pig 1
Hygiene
Dirty pens Pig 2 1
Management
Non-conventional management
systems (e.g. organic,
antimicrobial-free, extensive)
Chicken,
cow, pig
2 63 118
All-in/all-out systems Pig 3 43 6
Increasing pen, group or herd
size
Cow, pig 7 61
Fully slatted floors compared to
partially slatted
Pig 1 1
Heat or cold stress Pig 2
Education
Participation in a quality
assurance programme
Cow 5
Non-antimicrobial therapies
Treatment with an oral
competitive exclusion derived
from the intestinal tracts of
neonatal pigs
Pig 3 5
Oral recombinant β-lactamase
with parenteral administration
of ampicillin
Dog 3 6
NRC, National Research Council Canada.
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associated with an increase or decrease in the occur-
rence of antimicrobial resistance, or both). In light
of the general paucity of research in this area, we
did not identify any modifiable non-antimicrobial
factors or interventions that could on the basis of
available evidence be strongly recommended for con-
sideration, application or adoption by the North
American cattle industry without additional research,
or unless the factor(s) or intervention(s) have other
well established positive industry impacts and would
likely not propagate antimicrobial resistance.
When considering together the results of studies in
animal and human populations, some non-antimicro-
bial factors (e.g. health management, improving sani-
tation) may be sufficiently well-established principles
for disease prevention that they may not need ad-
ditional research; that is, before veterinarians and
beef producers could be convinced of the value in
adoption by the North American cattle industry.
Some of these factors (e.g. diet, reducing pen size,
heat/cold stressors, limiting contact with animals trea-
ted with antimicrobials, reducing time in a hospital
pen) may also result in other positive outcomes
(i.e. improved animal health and welfare, public
health, food safety) in addition to reducing antimicro-
bial resistance. To the extent that implementation of
such disease prevention strategies reduces the need
for antimicrobial treatment, benefits in reduced resist-
ance selection pressure could indirectly arise.
However, adoption by sectors of the cattle industry
may be technically or practically more difficult and re-
quire additional resources, changes to facility design,
management style, or systems. Regardless, additional
research is needed to adequately demonstrate the
efficacy of any of these factors to reduce the occur-
rence of antimicrobial resistance, either as a whole
or in specific ‘bug/drug’ combinations, in public health
or animal health settings.
One specific intervention that has been studied in
human populations, but not to our knowledge in cat-
tle populations, is the use of vaccination to address re-
sistance concerns in bacterial populations. There is
good evidence that pneumococcal vaccination reduces
antimicrobial resistance in pneumococcal bacteria in
humans. This finding has been attributed to a reduced
incidence of disease and a shift to less phenotypically
Table 4. Distribution of categories of modifiable non-antimicrobial factors or inventions described retained citations
in human populations (n = 356) where there was a statistically significant association with antimicrobial resistance
Category Factors or intervention Decrease Increase
Biocides or
disinifectants
Antiseptic soap or hand sanitizers, benzalkonium, biocides, chlorhexidine,
disinfectant, ethdium bromide, house cleaning solution, pine oil, triclosan
0 5
Hospital-related
factors
Increasing length of hospitalization or time spent in an intensive care unit or
other ward
0 289
Colonization pressure 0 8
Daycare 0 3
Infectious disease consultation 1 1
Interval between hospitalizations 0 0
Long-term care 1 8
Hospital size 0 1
Multiple visits to a hospital 0 0
Overcrowding 0 2
Transfers between units 0 11
Individual-level
factors
Aspirin/salicylic acid 0 3
Breast milk 1 0
Hamycin treatment 0 0
Immunosuppresives 1 13
Lactobacillus inocula 0 0
Laparotomy vs. laproscopy 0 0
Pneumonoccal vaccination 14 0
Sucralfate 0 2
Total citations 18 364
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resistant pneumococcal strains. In cattle studies, vacci-
nation for bovine respiratory disease complex or
undifferentiated fever was associated with reduced
frequency of respiratory disease and systemic antimi-
crobial treatment [22, 23]; however, effects on antimi-
crobial susceptibility were not reported. It would be
helpful if future studies of vaccine efficacy in food ani-
mals included evaluation of effect on antimicrobial re-
sistance in both the pathogen of interest and
commensal bacteria in target (e.g. lung) and non-
target sites, such as the gastrointestinal tract.
Several knowledge gaps were identified concerning
non-antimicrobial interventions against resistance.
For example, no studies were found on the impact
on resistance of some common North American cattle
industry practices such as preconditioning (as a whole)
or factors associated with preconditioning (e.g. vacci-
nation, reducing stressors associated with weaning,
transportation, feed introduction), the impact of dif-
ferent bedding packs and materials, the use of hospital
or sick pens vs. ‘treat and go-home’ practices, impact
of veterinary consultations, and other educational
actions directed at producers. Factors such as mixing
groups of treated and untreated animals, open vs.
closed population management, and all-in/all-out sys-
tems that have been studied in other animal species (e.
g. pigs) need to be assessed for relevance to the various
cattle production sectors. Associations between biose-
curity measures in cattle production and antimicrobial
resistance are also areas worthy of additional research,
based on the findings in human populations related to
time spent in the hospital or intensive care wards.
Although the findings of this review may be limited
by the decision to not update from 2011 the searches
during the review process, it has been reported that
updates to Cochrane Reviews altered conclusions in
only 9% of updated reviews [24, 25]. Our review in-
cluded comprehensive searches (multiple databases
and all years searched) and, a large number of cita-
tions screened (27 060). To our knowledge, similar
reviews have not been published. The findings provide
a baseline for evidence-based recommendations on
Table 5. Common themes of modifiable non-antimicrobial factors or interventions reported in citations from retained
animal, human or in vitro populations
Factors from
Common themes Human or in vitro populations (n= 356 references) Animal populations (n= 39 references)
Cleaning and disinfection Various biocides, disinfectants and hand cleaners/
sanitizers
Cleaning and disinfection, hygiene and
sanitation
Relationships with
professionals
Infectious disease consultation, multiple visits to a
hospital
Participation in a quality assurance
programme
Hospital vs. home pens Colonization pressure, daycare, interval between
hospitalizations, residence in LTC, hospital size,
crowding, transfer between units
Herd/pen/group size, crowding,
contact with animals treated with
antimicrobials
Probiotic Lactobacillus inocula S. cerevisiae boulardii, porcine
competitive exclusion culture
Vaccination Pneumococcal vaccination Anti-Salmonella antibody
Housing Ventilation and flooring systems
Non-conventional
management systems
ABF, organic, animal friendly,
ecological
Temperature stress Cold/heat stress
Minerals Zinc and copper
Recombinant
β-lactamases
Recombinant β-lactamase
Health status Immunosuppressives Health status, comorbidity, routine
deworming
Gastric/ruminal pH Sucralfate High vs. low pH
Availability of feed Ad libitum vs. restricted
Energy sources Corn (dry, rolled, flaked steamed), wet
distillers, whey
Feed form Pelleted, mash, liquid
Group size Hospital size Group/pen/herd size
LTC, Long-term care; ABF, antibiotic free.
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interventions to reduce the occurrence of antimicro-
bial resistance, identify areas for future research in-
cluding knowledge gaps and establish a framework
upon which data from more recent and future studies
can be added.
The findings may also have been limited by the de-
cision to include only English language publications,
but the impact of this is difficult to determine
[26, 27]; other agri-food reviews have reported that
the number of relevant non-English-language citations
were few and therefore unlikely to impact findings [25].
As many of the countries with influential research on
antimicrobial resistance publish in English-language
peer-reviewed journals or provide other documents in
English, this potential bias was likely small.
CONCLUSION
A diverse but shallow body of evidence presents inves-
tigated factors or interventions associated with antimi-
crobial resistance and the addition of human studies
strengthened the data reported in animal populations.
However, the results of this review could not identify
any modifiable non-antimicrobial factors or interven-
tions that could be recommended for consideration,
application or adoption by the North American cattle
industry without additional research. Research is
needed to more comprehensively study these interven-
tions on the occurrence of antimicrobial resistance as
a whole and in specific ‘bug/drug’ combinations of
public and animal health interest.
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